GLOBAL BIOCHIPS MARKET 2019-2027

Lifesciences | Diagnostic & Biotechnology

GLOBAL BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Material, End Users And Geography | Forecasts 2019-2027

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

After a detailed analysis, Triton has concluded that the global biochips market is expected to display an upward trend in terms of revenue and is estimated to grow at a CAGR of 19.32% from 2019 to 2027. The market was assessed to be worth $11136.62 million in the year 2018 and is predicted to generate a revenue of approximately $52833.98 million by the year 2027.

Biochips are the gathering of diminished test sites or microarrays that are arranged on a solid underlying layer that allows to perform a variety of tests at the same time for better throughput and speed. Specifically, a biochip's surface area is smaller than or equal to a fingernail. Similar to a computer chip that has the ability to perform several mathematical procedures in a second, a biochip possesses the capability of accomplishing a variety of biological reactions (such as decoding genes) in few seconds.

global biochips market is expected to display an upward trend in terms of revenue and is estimated to grow at a CAGR of 19.32%

We provide additional customization based on your specific requirements. Request For Customization  

Digital microfluidic biochips have become one of the rising technologies in various biomedical fields. In this technology, a group of adjacent cells in the microfluidic array can be configured to work as storage, functional operations and also for transporting fluid droplets dynamically.

The sensors are placed on a flat inner layer that can be passive like silicon or glass or active, including integrated electronics or micromechanical devices that execute or aids the signal transduction, which can be analyzed later. By using surface chemistry, the sensor molecules are bound to the substrate with the help of covalent. The production of microarrays, which is non-trivial and an acute economic and technological restraint can decide the future of biochips.

The process of placing each sensor at a specific position (typically on a Cartesian grid) on the substrate is the primary manufacturing challenge. Out of various means which exist to achieve the placement, the robotic micro-pipetting or micro-printing systems are used to place tiny spots of sensor material on the chip surface. As each sensor is unique, only a few spots can be placed at a time.

In the biochips market report from Triton, market definition and the key insights regarding the industry are discussed. Also, the market attractiveness matrix, vendor scorecard, Porter's five force analysis, key impact analysis, industrial components, regulatory framework, market opportunity insights, industrial player positioning and key market strategies are studied in detail.

The market drivers like growth in personalized medicines market, rising incidences and treatment of cancer, the global increase in the spending on healthcare and rising investments in biotechnology R&D are analyzed in the report. The industry is facing market restraints like inequality in healthcare access, inadequate technical awareness related to biochips and complexity of biological systems are some of the obstructing factors for the growth of the market.

Market By Type, Substrate Material, End Users And Geography | Forecasts 2019-2027

To get detailed insights on segments, Request Free Sample Report  

The key opportunities like developments in biochips technology, lucrative growth in the Asia-Pacific region and growing application areas of biochips can be leveraged by the industry to reach towards the projected growth over the forecasting years. However, challenges such as availability of substitute technology, unclear regulatory guideline and cost constraints are restricting the growth in the market.

The key geographies covered in the biochips market are:

o          North America Biochips Market: United States and Canada

o          Europe Biochips Market: United Kingdom, Germany, France, Italy, Spain, Russia and Rest of Europe

o          Asia Pacific Biochips Market: China, Japan, India, South Korea, ASEAN countries, Australia & New Zealand and Rest of Asia Pacific

o          Latin America Biochips Market: Brazil, Mexico and Rest of Latin America

o          The Middle East and Africa Biochips Market: United Arab Emirates, Turkey, Saudi Arabia, South Africa and Rest of the Middle East and Africa

The global biochips market is segmented as follows:

•           The type segment includes:

o          DNA chips:

•           Agricultural biotechnology

•           Cancer diagnostics and treatment

•           Drug discovery

•           Gene expression

•           Genomics

•           Single nucleotide polymorphism (SNP) genotyping

•           Other DNA chips

o          Lab on a chip:

•           Clinical Diagnostics

•           Drug discovery

•           Genomics

•           Point of care and In vitro diagnosis

•           Proteomics

•           Other lab on a chip

o          Protein chips:

•           Diagnostics

•           Drug discovery

•           Expression profiling

•           High throughput screening

•           Proteomics

•           Other protein chips

o          Other chips:

•           Cell arrays

•           Tissue arrays

•           The substrate material segment includes:

o          Glass

o          Polymers

o          Silicon

o          Other substrate materials

•           The end users segment includes:

o          Biotechnology and pharmaceutical companies

o          Hospital and diagnostics centers

o          Academic and research institute

The dominant players in the biochips market include Agilent Technology Inc., Cybrdi Inc., Biochain Institute Inc., Fluidigm Corporation, Biomerieux SA, Gamida for Life Group, Bio-rad Laboratories Inc., Illumina Inc., Cepheid Inc., and Imgenex.

The strategic analysis for each of these companies in the biochips market is covered in detail. The company market share helps to dive into the information about the key players and their hold on the market.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1.    BIOCHIPS MARKET - SUMMARY

2.    INDUSTRY OUTLOOK

2.1. MARKET DEFINITION

2.2. KEY INSIGHTS

2.3. EVOLUTION & TRANSITION OF BIOCHIPS

2.4. PORTER'S FIVE FORCE ANALYSIS

2.5. MARKET ATTRACTIVENESS MATRIX

2.6. INDUSTRY COMPONENTS

2.7. REGULATORY FRAMEWORK

2.8. VENDOR SCORECARD

2.9. KEY IMPACT ANALYSIS

2.10.            MARKET OPPORTUNITY INSIGHTS

2.11.            INDUSTRY PLAYER POSITIONING

2.12.            KEY MARKET STRATEGIES

2.13.            MARKET DRIVERS

2.13.1.                GROWTH IN PERSONALIZED MEDICINES

2.13.2.                RISING INCIDENCES & TREATMENT OF CANCER

2.13.3.                CONSTANT RISE IN HEALTHCARE SPENDING WORLDWIDE

2.13.4.                INCREASING NUMBER OF INVESTMENTS IN BIOTECHNOLOGY R&D

2.14.            MARKET RESTRAINTS

2.14.1.                INEQUALITIES IN HEALTHCARE ACCESS

2.14.2.                INADEQUATE TECHNICAL AWARENESS RELATED TO BIOCHIPS

2.14.3.                COMPLEXITY OF BIOLOGICAL SYSTEMS

2.15.            MARKET OPPORTUNITIES

2.15.1.                DEVELOPMENTS IN BIOCHIPS TECHNOLOGY

2.15.2.                ASIA PACIFIC TO OFFER LUCRATIVE GROWTH OPPORTUNITIES

2.15.3.                WIDENING APPLICATION AREAS OF BIOCHIPS

2.16.            MARKET CHALLENGES

2.16.1.                AVAILABILITY OF SUBSTITUTE TECHNOLOGIES

2.16.2.                UNCLEAR REGULATORY GUIDELINES

2.16.3.                COST CONSTRAINTS

3.    BIOCHIPS INDUSTRY OUTLOOK – BY TYPE

3.1. DNA CHIPS

3.1.1.   AGRICULTURAL BIOTECHNOLOGY

3.1.2.   CANCER DIAGNOSTICS & TREATMENT

3.1.3.   DRUG DISCOVERY

3.1.4.   GENE EXPRESSION

3.1.5.   GENOMICS

3.1.6.   SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING

3.1.7.   OTHER DNA CHIPS

3.2. LAB ON A CHIP

3.2.1.   CLINICAL DIAGNOSTICS

3.2.2.   DRUG DISCOVERY

3.2.3.   GENOMICS

3.2.4.   POINT OF CARE & IN VITRO DIAGNOSIS

3.2.5.   PROTEOMICS

3.2.6.   OTHER LAB ON A CHIP

3.3. PROTEIN CHIPS

3.3.1.   DIAGNOSTICS

3.3.2.   DRUG DISCOVERY

3.3.3.   EXPRESSION PROFILING

3.3.4.   HIGH THROUGHPUT SCREENING

3.3.5.   PROTEOMICS

3.3.6.   OTHER PROTEIN CHIPS

3.4. OTHER CHIPS

3.4.1.   CELL ARRAYS

3.4.2.   TISSUE ARRAYS

4.    BIOCHIPS INDUSTRY OUTLOOK - BY SUBSTRATE MATERIAL

4.1. GLASS

4.2. POLYMERS

4.3. SILICON

4.4. OTHER SUBSTRATE MATERIALS

5.    BIOCHIPS INDUSTRY OUTLOOK - BY END USER

5.1. BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES

5.2. HOSPITALS AND DIAGNOSTICS CENTERS

5.3. ACADEMIC AND RESEARCH INSTITUTE

6.    BIOCHIPS INDUSTRY - REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1.   MARKET BY TYPE

6.1.2.   MARKET BY SUBSTRATE MATERIAL

6.1.3.   MARKET BY END USER

6.1.4.   COUNTRY ANALYSIS

6.1.4.1.      UNITED STATES

6.1.4.2.      CANADA

6.2. EUROPE

6.2.1.   MARKET BY TYPE

6.2.2.   MARKET BY SUBSTRATE MATERIAL

6.2.3.   MARKET BY END USER

6.2.4.   COUNTRY ANALYSIS

6.2.4.1.      UNITED KINGDOM

6.2.4.2.      GERMANY

6.2.4.3.      FRANCE

6.2.4.4.      ITALY

6.2.4.5.      SPAIN

6.2.4.6.      RUSSIA

6.2.4.7.      REST OF EUROPE

6.3. ASIA PACIFIC

6.3.1.   MARKET BY TYPE

6.3.2.   MARKET BY SUBSTRATE MATERIAL

6.3.3.   MARKET BY END USER

6.3.4.   COUNTRY ANALYSIS

6.3.4.1.      CHINA

6.3.4.2.      JAPAN

6.3.4.3.      INDIA

6.3.4.4.      SOUTH KOREA

6.3.4.5.      ASEAN COUNTRIES

6.3.4.6.      AUSTRALIA AND NEW ZEALAND

6.3.4.7.      REST OF ASIA PACIFIC

6.4. LATIN AMERICA

6.4.1.   MARKET BY TYPE

6.4.2.   MARKET BY SUBSTRATE MATERIAL

6.4.3.   MARKET BY END USER

6.4.4.   COUNTRY ANALYSIS

6.4.4.1.      BRAZIL

6.4.4.2.      MEXICO

6.4.4.3.      REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1.   MARKET BY TYPE

6.5.2.   MARKET BY SUBSTRATE MATERIAL

6.5.3.   MARKET BY END USER

6.5.4.   COUNTRY ANALYSIS

6.5.4.1.      UNITED ARAB EMIRATES

6.5.4.2.      TURKEY

6.5.4.3.      SAUDI ARABIA

6.5.4.4.      SOUTH AFRICA

6.5.4.5.      REST OF MIDDLE EAST & AFRICA

7.    COMPETITIVE LANDSCAPE

7.1. AGILENT TECHNOLOGY INC.

7.2. BIOCHAIN INSTITUTE INC.

7.3. BIOMERIEUX SA

7.4. BIO-RAD LABORATORIES INC.

7.5. CEPHEID INC.

7.6. CYBRDI INC.

7.7. FLUIDIGM CORPORATION

7.8. GAMIDA FOR LIFE GROUP

7.9. ILLUMINA INC.

7.10.            IMGENEX

7.11.            MERCK GMBH

7.12.            ORIGENE TECHNOLOGIES INC.

7.13.            PERKINELMER INC.

7.14.            SAMSUNG ELECTRONICS INC.

7.15.            THERMO FISHER SCIENTIFIC INC.

8.    METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE

8.2. SOURCES OF DATA

8.3. RESEARCH METHODOLOGY

List of table

TABLE 1. MARKET ATTRACTIVENESS MATRIX FOR BIOCHIPS MARKET       

TABLE 2. VENDOR SCORECARD OF BIOCHIPS MARKET

TABLE 3. REGULATORY FRAMEWORK OF BIOCHIPS MARKET

TABLE 4. KEY STRATEGIC DEVELOPMENTS IN BIOCHIPS MARKET

TABLE 5. ESTIMATED NUMBER OF NEW CANCER CASES & ESTIMATED DEATHS DUE TO CANCER IN UNITED STATES IN 2017 

TABLE 6. NOTABLE INVESTMENTS MADE IN BIOTECHNOLOGY INDUSTRY IN 2017          

TABLE 7. ESTIMATED R&D EXPENDITURE IN MEDICAL & HEALTHCARE INDUSTRY OF THE UNITED STATES, 2013-2015 (IN $ MILLIONS)

TABLE 8. ESTIMATED R&D SPENDING IN BIOTECHNOLOGY, PHARMACEUTICAL, & MEDICAL INDUSTRY OF UNITED STATES, 2013-2015 (IN $ MILLIONS)

TABLE 9. GLOBAL BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)  

TABLE 10. GLOBAL BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)      

TABLE 11. GLOBAL BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)  

TABLE 12. GLOBAL BIOCHIPS MARKET, REGIONAL OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 13. NORTH AMERICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 14. NORTH AMERICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)       

TABLE 15. NORTH AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)

TABLE 16. NORTH AMERICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)           

TABLE 17. EUROPE BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 18. EUROPE BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)           

TABLE 19. EUROPE BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)      

TABLE 20. EUROPE BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION) 

TABLE 21. ASIA PACIFIC BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 22. ASIA PACIFIC BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)  

TABLE 23. ASIA PACIFIC BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)

TABLE 24. ASIA PACIFIC BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)    

TABLE 25. LATIN AMERICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 26. LATIN AMERICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)         

TABLE 27. LATIN AMERICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)

TABLE 28. LATIN AMERICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)           

TABLE 29. MIDDLE EAST & AFRICA BIOCHIPS MARKET, COUNTRY OUTLOOK, 2019-2027 (IN $ MILLION)

TABLE 30. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY TYPE, 2019-2027 (IN $ MILLION)           

TABLE 31. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY SUBSTRATE MATERIAL, 2019-2027 (IN $ MILLION)          

TABLE 32. MIDDLE EAST & AFRICA BIOCHIPS MARKET, BY END USER, 2019-2027 (IN $ MILLION)

List of Figures

FIGURE 1. GLOBAL BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)       

FIGURE 2. PORTER’S FIVE FORCE ANALYSIS OF BIOCHIPS MARKET

FIGURE 3. KEY IMPACT ANALYSIS

FIGURE 4. TIMELINE OF BIOCHIPS

FIGURE 5. MARKET OPPORTUNITY INSIGHTS, BY REGION, 2018

FIGURE 6. MARKET OPPORTUNITY INSIGHTS, BY TYPE, 2018

FIGURE 7. MARKET OPPORTUNITY INSIGHTS, BY END USER, 2018   

FIGURE 8. INDUSTRY COMPONENTS OF BIOCHIPS MARKET   

FIGURE 9. KEY PLAYERS POSITIONING IN 2018 (%)

FIGURE 10. WORLDWIDE HEALTHCARE SPENDING, BY REGIONS, 2014-2015 (% OF GDP)           

FIGURE 11. UNITED STATES HEALTHCARE SPENDING, 2015-2025 (% OF GDP)     

FIGURE 12. COMPARISON OF HEALTHCARE SPENDING PER CAPITA AND OUT OF THE POCKET HEALTH EXPENDITURE        

FIGURE 13. GLOBAL BIOCHIPS MARKET, BY DNA CHIPS, 2019-2027 (IN $ MILLION)          

FIGURE 14. GLOBAL DNA CHIPS MARKET, BY AGRICULTURAL BIOTECHNOLOGY, 2019-2027 (IN $ MILLION)

FIGURE 15. GLOBAL DNA CHIPS MARKET, BY CANCER DIAGNOSTICS & TREATMENT, 2019-2027 (IN $ MILLION)

FIGURE 16. GLOBAL DNA CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)           

FIGURE 17. GLOBAL DNA CHIPS MARKET, BY GENE EXPRESSION, 2019-2027 (IN $ MILLION)           

FIGURE 18. GLOBAL DNA CHIPS MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)        

FIGURE 19. GLOBAL DNA CHIPS MARKET, BY SINGLE NUCLEOTIDE POLYMORPHISM (SNP) GENOTYPING, 2019-2027 (IN $ MILLION)       

FIGURE 20. GLOBAL DNA CHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)  

FIGURE 21. GLOBAL BIOCHIPS MARKET, BY LAB ON A CHIP, 2019-2027 (IN $ MILLION)   

FIGURE 22. GLOBAL LAB ON A CHIP MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 23. GLOBAL LAB ON A CHIP MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 24. GLOBAL LAB ON A CHIP MARKET, BY GENOMICS, 2019-2027 (IN $ MILLION)

FIGURE 25. GLOBAL LAB ON A CHIP MARKET, BY POINT OF CARE & IN VITRO DIAGNOSIS, 2019-2027 (IN $ MILLION)

FIGURE 26. GLOBAL LAB ON A CHIP MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)           

FIGURE 27. GLOBAL LAB ON A CHIP MARKET, BY OTHER LAB ON A CHIP, 2019-2027 (IN $ MILLION)

FIGURE 28. GLOBAL BIOCHIPS MARKET, BY PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 29. GLOBAL PROTEIN CHIPS MARKET, BY DIAGNOSTICS, 2019-2027 (IN $ MILLION)

FIGURE 30. GLOBAL PROTEIN CHIPS MARKET, BY DRUG DISCOVERY, 2019-2027 (IN $ MILLION)

FIGURE 31. GLOBAL PROTEIN CHIPS MARKET, BY EXPRESSION PROFILING, 2019-2027 (IN $ MILLION)

FIGURE 32. GLOBAL PROTEIN CHIPS MARKET, BY HIGH THROUGHPUT SCREENING, 2019-2027 (IN $ MILLION)

FIGURE 33. GLOBAL PROTEIN CHIPS MARKET, BY PROTEOMICS, 2019-2027 (IN $ MILLION)

FIGURE 34. GLOBAL PROTEIN CHIPS MARKET, BY OTHER PROTEIN CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 35. GLOBAL BIOCHIPS MARKET, BY OTHER CHIPS, 2019-2027 (IN $ MILLION)

FIGURE 36. GLOBAL OTHER BIOCHIPS MARKET, BY CELL ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 37. GLOBAL OTHER BIOCHIPS MARKET, BY TISSUE ARRAYS, 2019-2027 (IN $ MILLION)

FIGURE 38. GLOBAL BIOCHIPS MARKET, BY GLASS, 2019-2027 (IN $ MILLIONS)    

FIGURE 39. GLOBAL BIOCHIPS MARKET, BY POLYMERS, 2019-2027 (IN $ MILLIONS)

FIGURE 40. GLOBAL BIOCHIPS MARKET, BY SILICON, 2019-2027 (IN $ MILLIONS)

FIGURE 41. GLOBAL BIOCHIPS MARKET, BY OTHER SUBSTRATE MATERIALS, 2019-2027 (IN $ MILLIONS)

FIGURE 42. GLOBAL BIOCHIPS MARKET, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2019-2027 (IN $ MILLIONS)

FIGURE 43. GLOBAL BIOCHIPS MARKET, BY HOSPITALS AND DIAGNOSTICS CENTERS, 2019-2027 (IN $ MILLIONS)

FIGURE 44. GLOBAL BIOCHIPS MARKET, BY ACADEMIC AND RESEARCH INSTITUTE, 2019-2027 (IN $ MILLIONS)

FIGURE 45. GLOBAL BIOCHIPS MARKET, REGIONAL OUTLOOK, 2018 & 2027 (IN %)         

FIGURE 46. UNITED STATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 

FIGURE 47. CANADA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)    

FIGURE 48. UNITED KINGDOM BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)          

FIGURE 49. GERMANY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 

FIGURE 50. FRANCE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)    

FIGURE 51. ITALY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)          

FIGURE 52. SPAIN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)         

FIGURE 53. RUSSIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)      

FIGURE 54. REST OF EUROPE BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)         

FIGURE 55. CHINA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)        

FIGURE 56. JAPAN BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)        

FIGURE 57. INDIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)          

FIGURE 58. SOUTH KOREA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)    

FIGURE 59. ASEAN COUNTRIES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)       

FIGURE 60. AUSTRALIA & NEW ZEALAND BIOCHIPS MARKET, 2019-2027 (IN $ MILLION) 

FIGURE 61. REST OF ASIA-PACIFIC BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

FIGURE 62. BRAZIL BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)       

FIGURE 63. MEXICO BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)     

FIGURE 64. REST OF LATIN AMERICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

FIGURE 65. UNITED ARAB EMIRATES BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)        

FIGURE 66. SAUDI ARABIA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)     

FIGURE 67. TURKEY BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)     

FIGURE 68. SOUTH AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)   

FIGURE 69. REST OF MIDDLE EAST & AFRICA BIOCHIPS MARKET, 2019-2027 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;